Genetic Technologies Limited (GTG.AX)
AUD 0.04
(0.0%)
AUD 0.04
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 4.35 Million AUD | 17.93% |
| 2023 | 3.69 Million AUD | -15.49% |
| 2022 | 4.37 Million AUD | 203.8% |
| 2021 | 1.43 Million AUD | -12.3% |
| 2020 | 1.64 Million AUD | 9.81% |
| 2019 | 1.49 Million AUD | 2.73% |
| 2018 | 1.45 Million AUD | -4.91% |
| 2017 | 1.52 Million AUD | 8.73% |
| 2016 | 1.4 Million AUD | -20.11% |
| 2015 | 1.76 Million AUD | -64.08% |
| 2014 | 4.9 Million AUD | 91.38% |
| 2013 | 2.56 Million AUD | 25.61% |
| 2012 | 2.03 Million AUD | -3.28% |
| 2011 | 2.1 Million AUD | -17.7% |
| 2010 | 2.56 Million AUD | -46.51% |
| 2009 | 4.78 Million AUD | 44.42% |
| 2008 | 3.31 Million AUD | -18.12% |
| 2007 | 4.05 Million AUD | -3.01% |
| 2006 | 4.17 Million AUD | -35.85% |
| 2005 | 6.5 Million AUD | 22.35% |
| 2004 | 5.32 Million AUD | 79.25% |
| 2003 | 2.96 Million AUD | 59.17% |
| 2002 | 1.86 Million AUD | 15.24% |
| 2001 | 1.61 Million AUD | 27.42% |
| 2000 | 1.26 Million AUD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q4 | 4.35 Million AUD | 0.0% |
| 2024 Q2 | 3.65 Million AUD | 0.0% |
| 2024 FY | 4.35 Million AUD | 17.93% |
| 2023 Q2 | 4.66 Million AUD | 0.0% |
| 2023 FY | 3.69 Million AUD | -15.49% |
| 2023 Q4 | 3.69 Million AUD | 0.0% |
| 2022 Q1 | 2.77 Million AUD | 92.62% |
| 2022 FY | 4.37 Million AUD | 203.8% |
| 2022 Q3 | 3.81 Million AUD | 23.31% |
| 2022 Q4 | 4.37 Million AUD | 14.66% |
| 2022 Q2 | 3.09 Million AUD | 11.55% |
| 2021 Q2 | 1.36 Million AUD | 0.0% |
| 2021 FY | 1.43 Million AUD | -12.3% |
| 2021 Q3 | 1.4 Million AUD | 3.14% |
| 2021 Q4 | 1.43 Million AUD | 2.37% |
| 2020 FY | 1.64 Million AUD | 9.81% |
| 2020 Q2 | 1.48 Million AUD | 0.0% |
| 2020 Q4 | 2.61 Million AUD | 0.0% |
| 2019 FY | 1.49 Million AUD | 2.73% |
| 2019 Q2 | 1.09 Million AUD | 0.0% |
| 2019 Q4 | 1.49 Million AUD | 0.0% |
| 2018 FY | 1.45 Million AUD | -4.91% |
| 2018 Q2 | 1.21 Million AUD | 0.0% |
| 2018 Q4 | 1.45 Million AUD | 0.0% |
| 2017 Q4 | 1.52 Million AUD | 0.0% |
| 2017 FY | 1.52 Million AUD | 8.73% |
| 2017 Q2 | 1.76 Million AUD | 0.0% |
| 2016 Q2 | 1.23 Million AUD | 0.0% |
| 2016 FY | 1.4 Million AUD | -20.11% |
| 2016 Q4 | 1.4 Million AUD | 0.0% |
| 2015 Q2 | 3.14 Million AUD | 0.0% |
| 2015 FY | 1.76 Million AUD | -64.08% |
| 2015 Q4 | 1.76 Million AUD | 0.0% |
| 2014 Q4 | 4.9 Million AUD | 0.0% |
| 2014 Q2 | 7.91 Million AUD | 0.0% |
| 2014 FY | 4.9 Million AUD | 91.38% |
| 2013 Q3 | 2.46 Million AUD | 29.38% |
| 2013 FY | 2.56 Million AUD | 25.61% |
| 2013 Q2 | 1.9 Million AUD | 0.0% |
| 2013 Q4 | 2.56 Million AUD | 3.9% |
| 2012 FY | 2.03 Million AUD | -3.28% |
| 2012 Q2 | 1.6 Million AUD | 0.0% |
| 2012 Q4 | 2.03 Million AUD | 0.0% |
| 2011 Q2 | 2.39 Million AUD | 0.0% |
| 2011 FY | 2.1 Million AUD | -17.7% |
| 2011 Q4 | 2.1 Million AUD | 0.0% |
| 2010 FY | 2.56 Million AUD | -46.51% |
| 2010 Q4 | 2.56 Million AUD | 0.0% |
| 2010 Q2 | 2.82 Million AUD | 0.0% |
| 2009 Q2 | 3.6 Million AUD | 0.0% |
| 2009 Q4 | 3.86 Million AUD | 0.0% |
| 2009 FY | 4.78 Million AUD | 44.42% |
| 2008 Q2 | 2.71 Million AUD | 0.0% |
| 2008 Q4 | 3.31 Million AUD | 0.0% |
| 2008 FY | 3.31 Million AUD | -18.12% |
| 2007 Q4 | 4.05 Million AUD | 0.0% |
| 2007 FY | 4.05 Million AUD | -3.01% |
| 2007 Q2 | 3.88 Million AUD | 0.0% |
| 2006 Q2 | 3.71 Million AUD | 0.0% |
| 2006 FY | 4.17 Million AUD | -35.85% |
| 2006 Q4 | 4.17 Million AUD | 0.0% |
| 2005 FY | 6.5 Million AUD | 22.35% |
| 2005 Q4 | 6.5 Million AUD | 0.0% |
| 2005 Q2 | 4.7 Million AUD | 0.0% |
| 2004 FY | 5.32 Million AUD | 79.25% |
| 2003 FY | 2.96 Million AUD | 59.17% |
| 2002 FY | 1.86 Million AUD | 15.24% |
| 2001 FY | 1.61 Million AUD | 27.42% |
| 2000 FY | 1.26 Million AUD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Australian Clinical Labs Limited | 415.29 Million AUD | 98.951% |
| BCAL Diagnostics Limited | 3.67 Million AUD | -18.463% |
| Genetic Signatures Limited | 6.18 Million AUD | 29.558% |
| Healius Limited | 1.94 Billion AUD | 99.776% |
| Imagion Biosystems Limited | 8.37 Million AUD | 47.983% |
| Integral Diagnostics Limited | 442.56 Million AUD | 99.016% |
| INOVIQ Ltd | 1.71 Million AUD | -153.354% |
| Microba Life Sciences Limited | 16.82 Million AUD | 74.108% |
| Monash IVF Group Limited | 261.81 Million AUD | 98.336% |
| Rhythm Biosciences Limited | 651.54 Thousand AUD | -568.584% |
| Sonic Healthcare Limited | 6.75 Billion AUD | 99.935% |